Diabetes treatment medications Avandia (rosiglitazone) and Actos (pioglitazone) were found to have the same risks of heart attack, heart complications, and death. The study found the risks for both diabetes drugs to be approximately 4%. The new study was published in the latest issue of Circulation: Cardiovascular Quality and Outcomes, an American Heart Association journal. Researchers at ...